Featured Research

from universities, journals, and other organizations

Rural Patients' Colon And Lung Cancers Diagnosed Earlier, Research Says

Date:
November 21, 2007
Source:
Dartmouth College
Summary:
Urban patients with colorectal and lung cancer are more likely than their rural counterparts to "present at a late stage" -- i.e. to not be seen by a doctor until their cancers are advanced and less treatable. This effect was seen even when the study controlled for other factors associated with late-stage presentation, such as age, race, gender, marital status, income level, and level of education.

Rural patients are often assumed to be the top truants in American medicine, not seeking medical attention until a condition is more advanced and less treatable. However, a new study by Dartmouth researchers suggests that urban, not rural, patients are most likely to slip through the cracks—at least when it comes to colorectal and lung cancer.

Looking at national data on those two types of cancer, the study found that urban patients tend to be diagnosed at a later stage than their rural counterparts—even when the study controlled for other factors associated with late-stage presentation, such as age, race, gender, marital status, income level, and level of education.

The paper, "Rural Versus Urban Colorectal and Lung Cancer Patients: Differences in Stage at Presentation," was published in the November 2007 Journal of the American College of Surgeons. The authors are Ian Paquette, a general surgery resident at the Dartmouth-Hitchcock Medical Center (DHMC), and Sam Finlayson, a DHMC surgeon and vice chair for academic affairs for the Department of Surgery of the Dartmouth Medical School.

The team's findings fly in the face of the anecdotal evidence, including the sorts of tales traded in the corridors of DHMC, which serves a rural slice of New Hampshire and Vermont. "Where we practice, most doctors can tell stories about patients who have presented at a very late stage of a disease, and we find it hard to imagine that they could have ignored their symptoms for so long," said Paquette.

Knowing which types of patients are more likely to present with more advanced cancers helps doctors better implement screening efforts, allowing them to diagnose patients at earlier stages and improve their prognoses, said Paquette. The study focused on colorectal and lung cancer because these are types that surgeons see frequently in their day-to-day practice.

The team looked at more than 125,000 people with colorectal cancer and more than 160,000 people with lung cancer, drawing on 2000-03 data from the National Cancer Institute's Surveillance, Epidemiology, and End Results database, which collects data on many different types of cancer from 18 states. They used the rural-urban continuum codes from the US Department of Agriculture to analyze the data as to whether patients lived in rural or urban areas.


Story Source:

The above story is based on materials provided by Dartmouth College. Note: Materials may be edited for content and length.


Cite This Page:

Dartmouth College. "Rural Patients' Colon And Lung Cancers Diagnosed Earlier, Research Says." ScienceDaily. ScienceDaily, 21 November 2007. <www.sciencedaily.com/releases/2007/11/071120130151.htm>.
Dartmouth College. (2007, November 21). Rural Patients' Colon And Lung Cancers Diagnosed Earlier, Research Says. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/11/071120130151.htm
Dartmouth College. "Rural Patients' Colon And Lung Cancers Diagnosed Earlier, Research Says." ScienceDaily. www.sciencedaily.com/releases/2007/11/071120130151.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins